Fenofibrate Tablet
Product Images NDC 0615-8270

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 0615-8270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Inc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fenofibrate Tabs 160mg 8270 Ajanta 1)

Chemical structure diagram of fenofibrate, illustrating the molecular components and bonds of the active ingredient fenofibrate as shown in the image.*

FDA Label Image

Principal Display Panel-fenofibrate 160mg Tab Bingo Label. (Fenofibrate Tabs 160mg 8270 Ajanta 2)

Fenofibrate Tabs USP 160 mg oral tablets label by NCS HealthCare of KY, Inc dba Vangard Labs. The label includes lot number 8270- and placeholder for expiration date, with packaging by Vangard in Glasgow, KY 42141. The label mentions storage conditions at 20°-25°C, dispensing instructions, and contains multiple barcodes for product identification and inventory use, with a quantity of 30 tablets indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.